-
Innovation Ranking
NewInnovation Ranking – TIM SpA
TIM SpA (TIM) is a provider of telecommunications services. It offers mobile and fixed telecom services, voice, messaging and data, internet, and broadband services. It offers fiber optic data transmission using full IP technology, such as DWDM and MPLS and residential broadband services, through Tim Brasil. The company’s Telecom Italia Sparkle group offers range of ICT solutions to internet service providers, media, and content players, over the top media services, application service providers, multinational enterprises, and fixed and mobile operators....
-
Product Insights
Sonden Aen Tim
Sonden Aen Tim is an Onshore Wind project located in Central Denmark, Denmark. The project came online in 2000. Empower your strategies with our Sonden Aen Tim report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance....
-
Company Insights
Innovation and Patenting activity of TIM SA Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of TIM SA Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Company Insights
Innovation and Patenting activity of TIM SpA Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of TIM SpA Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cobolimab in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cobolimab in Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cobolimab in Melanoma Drug Details: Cobolimab is under development for the treatment...
-
Sector Analysis
Italy Telcom Operators Country Intelligence Report
Italy Telecom Operators Country Intelligence Overview The total telecom and pay-TV service revenue in Italy reached $24.6 billion in 2023. The market size growth has been estimated to decline at a CAGR of more than 1% during 2023-2028. The local government is focused on boosting the country’s telecom sector with the implementation of its National Broadband plan and expanding the 5G mobile network in the country. Italy Telecom Services Market Outlook, 2023-2028 ($ Billion) Buy the Full Report to Gain...
-
Sector Analysis
Brazil Telecom Operators Country Intelligence Report
Brazil Telecom Operators Country Intelligence Overview The total telecom and pay-TV service revenue in Brazil reached $29.3 billion in 2022. The market size has been estimated to grow at a CAGR of more than 4% during 2022-2027, primarily driven by increasing demand for mobile and fixed broadband connectivity. The growth is also attributed to National broadband Initiative aimed at deploying fiber-optic high-capacity networks for data transmission and internet access in the country, along with regulator and telco initiatives to expand...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – MAS-825 in Hidradenitis Suppurativa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MAS-825 in Hidradenitis Suppurativa report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MAS-825 in Hidradenitis Suppurativa Drug Details: MAS-825 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cobolimab in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cobolimab in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cobolimab in Colorectal Cancer Drug Details: Cobolimab is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Surzebiclimab in Hypopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Surzebiclimab in Hypopharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Surzebiclimab in Hypopharyngeal Cancer Drug Details: Surzebiclimab (BGBA-425) is under development for...